Upregulation of IGF2 expression during vascular calcification

Journal of Molecular Endocrinology

Volumn 52, Issue 2, 2014, Pages 77-85

  Zhu, Dongxing ^a   Mackenzie, Neil C W ^a   Millan, Jose Luis ^b   Farquharson, Colin ^a   Macrae, Vicky E ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b BURNHAM INSTITUTE   (United States)

Author keywords

IGF2; NPP1; Vascular calcification; VSMC

Indexed keywords

IGF2; NPP1; VASCULAR CALCIFICATION; VSMC;

ANIMALS; AORTA; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION PROFILING; INSULIN-LIKE GROWTH FACTOR II; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHOSPHORIC DIESTER HYDROLASES; PROTEIN KINASES; PYROPHOSPHATASES; TRANSCRIPTOME; UP-REGULATION; VASCULAR CALCIFICATION;

EID: 84893900800     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-13-0136     Document Type: Article

References (47)

1. Belfiore A, Frasca F, Pandini G, Sciacca L & Vigneri R 2009 Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. Endocrine Reviews 30 586-623. (doi:10.1210/er.2008-0047)
2. Bower NI, de la Serrana DG, Cole NJ, Hollway GE, Lee HT, Assinder S & Johnston IA 2012 Stac3 is required for myotube formation and myogenic differentiation in vertebrate skeletal muscle. Journal of Biological Chemistry 287 43936-43949. (doi:10.1074/jbc. M112.361311)
3. Chao W & D'Amore PA 2008 IGF2: epigenetic regulation and role in development and disease. Cytokine and Growth Factor Reviews 19 111-120. (doi:10.1016/j.cytogfr.2008.01.005)
4. Chisalita SI, Johansson GS, Liefvendahl E, Bäck K & Arnqvist HJ 2009 Human aortic smooth muscle cells are insulin resistant at the receptor level but sensitive to IGF1 and IGF2. Journal of Molecular Endocrinology 43 231-239. (doi:10.1677/JME-09-0021)
5. Collett GD & Canfield AE 2005 Angiogenesis and pericytes in the initiation of ectopic calcification. Circulation Research 96 930-938. (doi:10.1161/ 01.RES.0000163634.51301.0d)
6. Cui H 2007 Loss of imprinting of IGF2 as an epigenetic marker for the risk of human cancer. Disease Markers 23 105-112. (doi:10.1155/2007/ 363464)
7. DeChiara TM, Robertson EJ & Efstratiadis A 1991 Parental imprinting of the mouse insulin-like growth factor II gene. Cell 64 849-859. (doi:10.1016/0092-8674(91)90513-X)
8. Demer LL & Tintut Y 2008 Vascular calcification: pathobiology of a multifaceted disease. Circulation 117 2938-2948. (doi:10.1161/ CIRCULATIONAHA.107.743161)
9. Eggenschwiler J, Ludwig T, Fisher P, Leighton PA, Tilghman SM & Efstratiadis A 1997 Mouse mutant embryos overexpressing IGF-II exhibit phenotypic features of the Beckwith-Wiedemann and Simpson-Golabi-Behmel syndromes. Genes and Development 11 3128-3142. (doi:10.1101/gad.11.23.3128)
10. Federici M, Porzio O, Zucaro L, Fusco A, Borboni P, Lauro D & Sesti G 1997 Distribution of insulin/insulin-like growth factor-I hybrid receptors in human tissues. Molecular and Cellular Endocrinology 129 121-126. (doi:10.1016/S0303-7207(97)04050-1)
11. Hamamura K, Zhang P & Yokota H 2008 IGF2-driven PI3 kinase and TGFb signaling pathways in chondrogenesis. Cell Biology International 32 1238-1246. (doi:10.1016/j.cellbi.2008.07.007)
12. Hardouin SN, Guo R, Romeo PH, Nagy A & Aubin JE 2011 Impaired mesenchymal stem cell differentiation and osteoclastogenesis in mice deficient for Igf2-P2 transcripts. Development 138 203-213. (doi:10.1242/dev.054916)
13. Huang MS, Sage AP, Lu J, Demer LL & Tintut Y 2008 Phosphate and pyrophosphate mediate PKA-induced vascular cell calcification. Biochemical and Biophysical Research Communications 374 553-558. (doi:10.1016/j.bbrc.2008.07.062)
14. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B & Speed TP 2003 Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Research 31 e15. (doi:10.1093/nar/gng015)
15. Johnson K, Polewski M & Terkeltaub RA 2008 Transglutaminase 2 is central to induction of the arterial calcification program by smooth muscle cells. Circulation Research 102 529-537. (doi:10.1161/CIRCRESAHA. 107.154260)
16. Kauffmann A, Gentleman R & Huber W 2009 arrayQualityMetrics - a bioconductor package for quality assessment of microarray data. Bioinformatics 25 415-416. (doi:10.1093/bioinformatics/btn647)
17. Kim KW, Bae SK, Lee OH, Bae MH, Lee MJ & Park BC 1998 Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma. Cancer Research 58 348-351.
18. Kok K, Geering B & Vanhaesebroeck B 2009 Regulation of phosphoinositide 3-kinase expression in health and disease. Trends in Biochemical Sciences 34 115-127. (doi:10.1016/j.tibs.2009.01.003)
19. Lee JE, Pintar J & Efstratiadis A 1990 Pattern of the insulin-like growth factor II gene expression during early mouse embryogenesis. Development 110 151-159.
20. Li X, Yang HY & Giachelli CM 2008 BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells. Atherosclerosis 199 271-277. (doi:10.1016/j.atherosclerosis. 2007.11.031)
21. Liang L, Guo WH, Esquiliano DR, Asai M, Rodriguez S, Giraud J, Kushner JA, White MF & Lopez MF 2010 Insulin-like growth factor 2 and the insulin receptor, but not insulin, regulate fetal hepatic glycogen synthesis. Endocrinology 151 741-747. (doi:10.1210/en.2009-0705)
22. Mackenzie NC, Zhu D, Longley L, Patterson CS, Komareddy S & MacRae VE 2011 MOVAS-1 cell line: a new in vitro model of vascular calcification. International Journal of Molecular Medicine 27 663-668. (doi:10.3892/ ijmm.2011.631)
23. Mackenzie NC, Huesa C, Rutsch F & MacRae VE 2012a New insights into NPP1 function: lessons from clinical and animal studies. Bone 51 961-968. (doi:10.1016/j.bone.2012.07.014)
24. Mackenzie NCW, Zhu D, Milne EM, van 't Hof R, Martin A, Quarles DL, Millán JL, Farquharson C & MacRae VE 2012b Altered bone development and an increase in FGF-23 expression in Enpp1K/Kmice. PLoS ONE 7 e32177. (doi:10.1371/journal.pone.0032177)
25. MacRae VE, Horvat S, Pells S, Dale H, Collinson RS, Pitsillides AA, Ahmed SF & Farquharson C 2009 Increased bone mass, altered trabecular architecture and modified growth plate organization in the growing skeleton of SOCS2 deficient mice. Journal of Cellular Physiology 218 276-284. (doi:10.1002/jcp.21593)
26. Monzack EL & Masters KS 2011 Can valvular interstitial cells become true osteoblasts? A side-by-side comparison. Journal of Heart Valve Disease 20 449-463.
27. Morison IM, Becroft DM, Taniguchi T, Woods CG & Reeve AE 1996 Somatic overgrowth associated with overexpression of insulin-like growth factor II. Nature Medicine 2 311-316. (doi:10.1038/nm0396-311)
28. Murshed M, Harmey D, Millán JL, McKee MD & Karsenty G 2005 Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes and Development 19 1093-1104. (doi:10.1101/gad.1276205)
29. Okawa A, Nakamura I, Goto S, Moriya H, Nakamura Y & Igegawa S 1998 Mutation in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine. Nature Genetics 19 271-273. (doi:10.1038/956)
30. Radcliff K, Tang TB, Lim J, Zhang Z, Abedin M, Demer LL & Tintut Y 2005 Insulin-like growth factor-I regulates proliferation and osteoblastic differentiation of calcifying vascular cells via extracellular signalregulated protein kinase and phosphatidylinositol 3-kinase pathways. Circulation Research 96 398-400. (doi:10.1161/01.RES.0000157671. 47477.71)
31. Randhawa GS, Cui H, Barletta JA, Strichman-Almashanu LZ, Talpaz M, Kantarjian H, Deisseroth AB, Champlin RC & Feinberg AP 1998 Loss of imprinting in disease progression in chronic myelogenous leukemia. Blood 91 3144-3147.
32. Roy J, Kazi M, Hedin U & Thyberg J 2001 Phenotypic modulation of arterial smooth muscle cells is associated with prolonged activation of ERK1/2. Differentiation 67 50-58. (doi:10.1046/j.1432-0436.2001.067001050.x)
33. Rutsch F, Vaingankar S, Johnson K, Goldfine I, Maddux B, Schauerte P, Kalhoff H, Sano K, Boisvert WA, Superti-Furga A et al. 2001 PC-1 nucleoside triphosphate pyrophosphohydrolase deficiency in idiopathic infantile arterial calcification. American Journal of Pathology 158 543-554. (doi:10.1016/S0002-9440(10)63996-X)
34. Rutsch F, Ruf N, Vaingankar S, Toliat MR, Suk A, Höhne W, Schauer G, Lehmann M, Roscioli T, Schnabel D et al. 2003 Mutations in Enpp1 are associated with 'idiopathic' infantile arterial calcification. Nature Genetics 34 379-381. (doi:10.1038/ng1221)
35. Salasznyk RM, Klees RF, Hughlock MK & Plopper GE 2004 ERK signaling pathways regulate the osteogenic differentiation of human mesenchymal stem cells on collagen I and vitronectin. Cell Communication & Adhesion 11 137-153. (doi:10.1080/15419060500242836)
36. Sali A, Favaloro JM, Terkeltaub R & Goding JW 1999 Germline deletion of the nucleoside triphosphate pyrophosphohydrolase (NTPPPH)plasma cell membrane glycoprotein-1 (PC-1)produces abnormal calcification of periarticular tissues. In Ecto-ATPases and Related Ectoenzymes, pp 267-282. Eds L Vanduffel & R Lemmems. The Netherlands: Shaker Publishing.
37. Shroff RC & Shanahan CM 2007 The vascular biology of calcification. Seminars in Dialysis 20 103-109. (doi:10.1111/j.1525-139X.2007. 00255.x)
38. Siddals KW, Allen J, Sinha S, Canfield AE, Kalra PA & Gibson JM 2011 Apposite insulin-like growth factor (IGF)receptor glycosylation is critical to the maintenance of vascular smooth muscle phenotype in the presence of factors promoting osteogenic differentiation and mineralization. Journal of Biological Chemistry 286 16623-16630. (doi:10.1074/jbc.M110.202929)
39. Speer MY, Chien YC, Quan M, Yang HY, Vali H, McKee MD & Giachelli CM 2005 Smooth muscle cells deficient in osteopontin have enhanced susceptibility to calcification in vitro. Cardiovascular Research 66 324-333. (doi:10.1016/j.cardiores.2005.01.023)
40. Sperandeo MP, Ungaro P, Vernucci M, Pedone PV, Cerrato F, Perone L, Casola S, Cubellis MV, Bruni CB, Andria G et al. 2000 Relaxation of insulin-like growth factor 2 imprinting and discordant methylation at KvDMR1 in two first cousins affected by Beckwith-Wiedemann and Klippel-Trenaunay-Weber syndromes. American Journal of Human Genetics 66 841-847. (doi:10.1086/302811)
41. Staines KA, Zhu D, Farquharson C & MacRae VE 2013 Identification of novel regulators of osteoblast matrix mineralization by time series transcriptional profiling. Journal of Bone and Mineral Metabolism [in press].
42. Toretsky JA & Helman LJ 1996 Involvement of IGF-II in human cancer. Journal of Endocrinology 149 367-372. (doi:10.1677/joe.0.1490367)
43. Vorwerk P, Wex H, Bessert C, Hohmann B, Schmidt U & Mittler U 2003 Loss of imprinting of IGF-II gene in children with acute lymphoblastic leukemia. Leukemia Research 27 807-812. (doi:10.1016/S0145- 2126(03)00014-6)
44. Zaina S, Pettersson L, Ahrén B, Brånén L, Hassan AB, Lindholm M, Mattsson R, Thyberg J & Nilsson J 2002 Insulin-like growth factor II plays a central role in atherosclerosis in a mouse model. Journal of Biological Chemistry 277 4505-4511. (doi:10.1074/jbc.M108061200)
45. Zhu D, Mackenzie NCW, Millan JL, Farquharson C & MacRae VE 2011 The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells. PLoS ONE 6 e19595. (doi:10.1371/journal.pone.0019595)
46. Zhu D, Mackenzie NC, Farquharson C & MacRae VE 2012 Mechanisms and clinical consequences of vascular calcification. Frontiers in Endocrinology 3 95. (doi:10.3389/fendo.2012.00095)
47. Zhu D, Mackenzie NC, Millan JL, Farquharson C & MacRae VE 2013 A protective role for FGF-23 in local defence against disrupted arterial wall integrity? Molecular and Cellular Endocrinology 372 1-11. (doi:10.1016/j.mce.2013.03.008)